Gene Expression Risk Scores for COVID-19 Illness Severity.
Gene Expression Risk Scores for COVID-19 Illness Severity.
复制标题
DOI:
10.1093/infdis/jiab568
复制
发表时间:
2023-02-01
期刊:
影响因子:
--
通讯作者:
Mariani TJ
中科院分区:
文献类型:
--
作者:
Peterson DR;Baran AM;Bhattacharya S;Branche AR;Croft DP;Corbett AM;Walsh EE;Falsey AR;Mariani TJ
The correlates of coronavirus disease 2019 (COVID-19) illness severity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are incompletely understood. We assessed peripheral blood gene expression in 53 adults with confirmed SARS-CoV-2 infection clinically adjudicated as having mild, moderate, or severe disease. Supervised principal components analysis was used to build a weighted gene expression risk score (WGERS) to discriminate between severe and nonsevere COVID-19. Gene expression patterns in participants with mild and moderate illness were similar, but significantly different from severe illness. When comparing severe versus nonsevere illness, we identified >4000 genes differentially expressed (false discovery rate < 0.05). Biological pathways increased in severe COVID-19 were associated with platelet activation and coagulation, and those significantly decreased with T-cell signaling and differentiation. A WGERS based on 18 genes distinguished severe illness in our training cohort (cross-validated receiver operating characteristic-area under the curve [ROC-AUC] = 0.98), and need for intensive care in an independent cohort (ROC-AUC = 0.85). Dichotomizing the WGERS yielded 100% sensitivity and 85% specificity for classifying severe illness in our training cohort, and 84% sensitivity and 74% specificity for defining the need for intensive care in the validation cohort. These data suggest that gene expression classifiers may provide clinical utility as predictors of COVID-19 illness severity. Transcriptomic analysis of peripheral blood from COVID-19 patients identified differentially expressed genes distinguishing subjects with severe disease from those with nonsevere disease. These markers correctly identified the hospitalization status of unrelated COVID-19 subjects with a high level of accuracy.
登录
查看更多内容
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
影响因子:
168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者:
Cao, Bin
影响因子:
4.6
作者:
Bhattacharya S;Rosenberg AF;Peterson DR;Grzesik K;Baran AM;Ashton JM;Gill SR;Corbett AM;Holden-Wiltse J;Topham DJ;Walsh EE;Mariani TJ;Falsey AR
通讯作者:
Falsey AR
影响因子:
64.5
作者:
Moderbacher, Carolyn Rydyznski;Ramirez, Sydney, I;Crotty, Shane
通讯作者:
Crotty, Shane
影响因子:
4.6
作者:
Li CX;Chen J;Lv SK;Li JH;Li LL;Hu X
通讯作者:
Hu X